KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EPS (Basic) (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of EPS (Basic) readings, the most recent being $4.44 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 11.28% to $4.44 in Q1 2026 year-over-year; TTM through Mar 2026 was $18.22, a 6.61% increase, with the full-year FY2025 number at $17.77, up 7.18% from a year prior.
  • EPS (Basic) hit $4.44 in Q1 2026 for Thermo Fisher Scientific, down from $5.22 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $5.66 in Q2 2022 to a low of $3.34 in Q2 2023.
  • Median EPS (Basic) over the past 5 years was $4.25 (2022), compared with a mean of $4.24.
  • The widest YoY moves for EPS (Basic): up 16.23% in 2023, down 40.99% in 2023.
  • Thermo Fisher Scientific's EPS (Basic) stood at $4.03 in 2022, then grew by 4.47% to $4.21 in 2023, then increased by 13.78% to $4.79 in 2024, then increased by 8.98% to $5.22 in 2025, then fell by 14.94% to $4.44 in 2026.
  • The last three reported values for EPS (Basic) were $4.44 (Q1 2026), $5.22 (Q4 2025), and $4.28 (Q3 2025) per Business Quant data.